Improving the proton therapy journey of cancer centers
When a cancer center decides to add proton therapy to its radiation oncology department, it makes a long-term commitment to therapeutic innovation and high-quality patient care. A question remains essential: how to select the best proton therapy equipment provider, to ensure optimal installation and best-in-class performance throughout the system’s lifecycle?
Does IBA support radiation oncology centers in improving their proton therapy journey?
Maximize cancer patient care with IBA's expertise and ProteusONE's versatility
In the ever-evolving landscape of cancer treatment, how can cancer centers ensure they provide the most advanced proton therapy treatment and highest-quality patient care?
First proton therapy system restoration at Massachusetts General Hospital
The journey of proton therapy for cancer treatment has been transformative, particularly at Massachusetts General Hospital (MGH). The discussion led by Dr. Helen Shih and Dr. Anthony Zietman highlights the advancements in proton therapy at MGH since its initial installation in the 1960s, and the excitement of the first restoration of a proton therapy system. Dr. Shih is the medical director of the Proton Therapy Center, specializing in brain and ocular tumors, while Dr. Zietman, former chief of Radiation Oncology, specializes in genitourinary (GU) oncology and has been using proton therapy since for almost four decades.
Shreveport’s Community Hospital opts for Proton Therapy
Dr. Lane Rosen, Director of Radiation Oncology at Willis Knighton Cancer Center in Shreveport, Louisiana, highlights the transformative impact of introducing proton therapy with the ProteusONE system at their facility. In this blog, he shares insights into how a community hospital can successfully implement proton therapy, traditionally reserved for larger academic centers.
A Medical Physicist’s Perspective on the Versatility of ProteusONE
What is the point of view of a medical physicist on the versatility of ProteusONE? In this article, Xuanfeng (Leo) Ding, PhD, the Lead Proton Physicist at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, emphasizes the groundbreaking versatility of the IBA ProteusONE system. In his opinion, the IBA ProteusONE system stands out as the world’s first versatile proton therapy system, used to treat a wide range of cancer sites.
Comparing supine and upright positioning in proton therapy
When considering the best positioning for proton therapy, the debate between supine and upright methods has gained traction in recent years. In this article, you will discover a radiation oncologist’s point of view in this debate, explained by Dr. Arie Dosoretz, radiation oncologist and managing partner for Advocate Radiation Oncology and Southwest Florida Proton in Fort Myers, Florida.
Benefits of adding proton therapy with ProteusONE
Proton therapy represents a significant advancement in radiation oncology. In this article, Dr. Craig Stevens, Chair of Radiation Oncology at Corewell Health’s William Beaumont University Hospital Proton Therapy Center, discusses the evolution and benefits of their ProteusONE system installed in 2017.
Boosting patient care and institutional growth with Proton Therapy
The University of Kansas Cancer Center has significantly enhanced patient care and institutional growth by integrating proton therapy into their treatment options. As a National Cancer Institute (NCI) designated Comprehensive Cancer Center, they recognized the need for advanced particle beam treatments for the diverse patient population they serve, particularly for their pediatric cancer patients. Darin Kistler, Senior Director of Radiation Services, describes the center's evolution since installing the ProteusONE proton therapy system in 2017.
A Medical Director’s Perspective on DynamicARC
DynamicARC promises to revolutionize proton therapy by providing faster, sharper and simpler treatments to enhance patient care. In this blog, Dr. Rohan Deraniyagala, Medical Director at William Beaumont Hospital, part of the Corewell Health System, explains the advantages of this innovative technology, highlighting its ability to provide quicker treatments as a primary benefit for cancer patients. Patients undergoing proton therapy with DynamicARC can find themselves on the treatment table for less time, which is a critical factor in their overall experience and comfort.1,2 The faster treatment may also result in increased efficiency, allowing hospitals to accommodate a higher throughput of patients, making a real difference in cancer care accessibility.3
The Future of Proton Therapy with DynamicARC
DynamicARC* represents a pivotal breakthrough in radiation therapy and in cancer treatment. In this blog, Dr. Craig Stevens, Professor and Chair of the Department of Radiation Oncology at William Beaumont Hospital, part of the Corewell Health System, emphasizes to what extent DynamicARC is key to the future of radiation therapy with protons, enabling a paradigm shift in cancer treatment.
The Strategic and Clinical Benefits of Compact Proton Therapy at TMUH
In the heart of Taipei, where every square meter is precious and the demand for advanced healthcare is ever-growing, Taipei Medical University Hospital (TMUH) redefined its approach to cancer care by integrating proton therapy as a core component of its world-class oncology program. At the core of this transformation is ProteusONE, IBA’s compact proton therapy system, selected for its ability to address the unique challenges of urban hospital environments while meeting TMUH’s clinical needs for precision and efficiency.
In this article, we dive into the expert testimonials of five TMUH leaders whose roles span the entire proton therapy ecosystem: from institutional leadership to hands-on patient care. Their combined insights reveal how ProteusONE has overcome spatial and operational constraints, redefined clinical efficiency, enhanced the patient experience, and strengthened TMUH’s institutional strategy in one of Asia’s most densely populated cities.
Compact Proton Therapy at IEO Milan: Precision, Comfort, and Future-Ready Care
Find out how ProteusONE at IEO Milan combines precision, patient comfort, and future-ready technology to set new standards in cancer care.
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.